4th Quarter - Report
XOMA CORPORATION (FKA XOMA (US) LLC) for XOMA CORPORATION (FKA XOMA (US) LLC)
Income
—
Expenses
$30,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues relating to the draft Tax Reform Act of 2014, all provisions pertaining to an orphan drug tax credit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BETH RADA | — |
Health Issues HCR
Issues relating to implementation of PL 111-148 "Patient Protection and Affordable Care Act of 2010," all provisions. HR 460 "Patients' Access to Treatment Act of 2013," all provisions. Issues relating to patient access to treatments and orphan drug incentives.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BETH RADA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.